Generex has 180 days to regain listing compliance
Generex Biotechnology has additional 180 calendar days to regain Nasdaq listing compliance
- On 3:48 pm EST, Tuesday November 10, 2009
WORCESTER, Mass. (AP) -- Generex Biotechnology Corp. said Tuesday it has an additional 180 calendar days to regain compliance with the NASDAQ Stock Market's listing maintenance requirements.
The company will regain compliance if the bid price of its common stock closes at $1 per share or more for a minimum of 10 consecutive business days before May 5, 2010.
Shares fell 1 cent to 54 cents in afternoon trading. The stock has traded between 8 cents and $1.14 over the past 52 weeks.
Related Headlines
- Generex Scientist Makes Presentation at National Influenza Congress - GlobeNewswire
- GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - EDGAR Online
- Generex has 180 days to regain listing compliance - AP
- Generex Receives Confirmation of Extension of Compliance Period From NASDAQ - GlobeNewswire
- Generex's Glucose RapidSpray(TM) Featured on Doggie Chronicles Radio - GlobeNewswire
Related Blog Headlines
- Four Biotech Stocks to Play the Sector Pullback - at Seeking Alpha
- A N.I.C.E. Development for Generex Oral-lyn in the U.K. - at Seeking Alpha
- Liking the Risk/Reward in Generex - at Seeking Alpha
- Why I'm Taking a Foothold in Generex Now - at Seeking Alpha
Sponsored Links
-
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT. -
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today.
-
Earn From 1.90% to 2.20% Apply Online
With GE Capital Corporation. Not An Offer Of Securities For Sale. -
Super Cheap Car Insurance
Get Discount Car Insurance Quotes Online – Rates from $15 / Month.
Tech Ticker Recent Posts
Add Alert Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.